Big Comeback for Myeloma Drug; DIY Cancer Therapy; Gut Clues to Bladder Cancer

(MedPage Today) -- GSK announced that belantamab mafodotin (Blenrep) plus bortezomib (Velcade) and dexamethasone improved overall survival in relapsed/refractory multiple myeloma as compared with daratumumab (Darzalex) plus bortezomib and dexamethasone...